- Home
- PBH vs MBLY Comparison
PBH vs MBLY Comparison
Compare PBH & MBLY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBH
- MBLY
- Stock Information
- Founded
- PBH 1996
- MBLY 1999
- Country
- PBH United States
- MBLY Israel
- Employees
- PBH N/A
- MBLY N/A
- Industry
- PBH Biotechnology: Pharmaceutical Preparations
- MBLY Computer Software: Prepackaged Software
- Sector
- PBH Health Care
- MBLY Technology
- Exchange
- PBH Nasdaq
- MBLY Nasdaq
- Market Cap
- PBH 4.1B
- MBLY 9.8B
- IPO Year
- PBH 2005
- MBLY 2022
- Fundamental
- Price
- PBH $87.06
- MBLY $15.68
- Analyst Decision
- PBH Buy
- MBLY Buy
- Analyst Count
- PBH 5
- MBLY 21
- Target Price
- PBH $94.00
- MBLY $21.11
- AVG Volume (30 Days)
- PBH 368.1K
- MBLY 3.5M
- Earning Date
- PBH 05-08-2025
- MBLY 04-24-2025
- Dividend Yield
- PBH N/A
- MBLY N/A
- EPS Growth
- PBH 2.88
- MBLY N/A
- EPS
- PBH 4.29
- MBLY N/A
- Revenue
- PBH $1,137,762,000.00
- MBLY $1,853,000,000.00
- Revenue This Year
- PBH $1.48
- MBLY $8.65
- Revenue Next Year
- PBH $2.28
- MBLY $19.42
- P/E Ratio
- PBH $20.26
- MBLY N/A
- Revenue Growth
- PBH 1.10
- MBLY N/A
- 52 Week Low
- PBH $62.35
- MBLY $10.48
- 52 Week High
- PBH $90.04
- MBLY $33.26
- Technical
- Relative Strength Index (RSI)
- PBH 62.76
- MBLY 61.30
- Support Level
- PBH $80.62
- MBLY $14.21
- Resistance Level
- PBH $84.90
- MBLY $14.94
- Average True Range (ATR)
- PBH 2.17
- MBLY 0.63
- MACD
- PBH 0.57
- MBLY 0.24
- Stochastic Oscillator
- PBH 97.20
- MBLY 93.23
About PBH Prestige Consumer Healthcare Inc.
Prestige Consumer Healthcare is one of the largest pure-play over-the-counter healthcare providers. It has a diverse portfolio composed of leading brands in niche consumer health categories. Prestige's key brands include Clear Eyes (redness relief), Dramamine (motion sickness relief), Monistat (vaginal anti-fungal), and Summer's Eve (feminine hygiene), and many of its brands enjoy category leadership and recommendations from medical professionals. The firm mainly plays in North America where it generates roughly 85% of its total revenue, and the remaining sales come from Australia, New Zealand, and certain Asian markets.
About MBLY Mobileye Global Inc.
Mobileye Global Inc engages in the development and deployment of ADAS and autonomous driving technologies and solutions. It is building a portfolio of end-to-end ADAS and autonomous driving solutions to provide the capabilities needed for the future of autonomous driving, leveraging a comprehensive suite of purpose-built software and hardware technologies. The company's reportable operating segment are Mobileye and Others. Its solutions comprise Driver Assist, Cloud-Enhanced Driver Assist, Mobileye SuperVision Lite, Mobileye SuperVision, Mobileye Chauffeur, Mobileye Drive, Self-Driving System & Vehicles. It derives maximum revenue from Mobileye Segment.